Arcus Biosciences logo
Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
22.51
-1.83 (-7.52%)
At close: Oct 13, 2026, 4:00 PM EDT
22.51
0.00 (0.00%)
After-hours: Oct 13, 2026, 4:10 PM EDT

Arcus Biosciences Revenue

Arcus Biosciences had revenue of $41.00M in the quarter ending June 30, 2026, a decrease of -74.38%. This brings the company's revenue in the last twelve months to $117.00M, down -55.34% year-over-year. In the year 2025, Arcus Biosciences had annual revenue of $247.00M, down -4.26%. That makes Arcus Biosciences the 21,450th largest company in the world by revenue and 3,194th in the United States.

Revenue (ttm)
$117.00M
Revenue Growth
-55.34%
P/S Ratio
24.50
Revenue / Employee
$194,676
Employees
601
Market Cap
2.87B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025247.00M-11.00M-4.26%
Dec 31, 2024258.00M141.00M120.51%
Dec 31, 2023117.00M5.00M4.46%
Dec 31, 2022112.00M-271.00M-70.76%
Dec 31, 2021383.00M305.00M391.03%
Dec 31, 202078.00M63.00M420.00%
Dec 31, 201915.00M6.65M79.58%
Dec 31, 20188.35M6.94M491.15%
Dec 31, 20171.41M--
Dec 31, 2016---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.